Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AtriCure, Inc. Director's Dealing 2025

Aug 7, 2025

31802_dirs_2025-08-07_e8367b13-52b5-4546-9598-cbc2ee7c609a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AtriCure, Inc. (ATRC)
CIK: 0001323885
Period of Report: 2025-08-05

Reporting Person: Doraiswamy Vinayak (Chief Scientific Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-08-05 Common Stock S 2500 $36.58 Disposed 71872 Direct